Thermo Fisher Scientific Inc. (TMO) Debt to Equity Ratio: 0.76
Is Thermo Fisher Scientific Inc.’s debt to equity ratio high or low?
Thermo Fisher Scientific Inc.'s debt to equity ratio of 0.76 is in line with its 5-year average of 0.76, around the middle of its 5-year range (0.65–0.89).
The debt to equity ratio for Thermo Fisher Scientific Inc. (TMO) is 0.76 as of Wednesday, June 10, 2026. It is above its 12-month average by 7.04% (0.71).
TMO Debt to Equity Ratio Chart
TMO Average Debt to Equity Ratio Chart
TMO Current vs Average Debt to Equity Ratio Chart
TMO Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
0.76
DEBT TO EQUITY RATIO AVG TTM
0.71
DEBT TO EQUITY RATIO AVG 3Y
0.76
DEBT TO EQUITY RATIO AVG 5Y
0.76
DEBT TO EQUITY RATIO AVG 10Y
0.73
DEBT TO EQUITY RATIO AVG 15Y
0.65
DEBT TO EQUITY RATIO AVG 20Y
0.54
CURRENT VS TTM AVG
+7.04%
CURRENT VS 3Y AVG
+0.66%
CURRENT VS 5Y AVG
+0.00%
CURRENT VS 10Y AVG
+3.85%
CURRENT VS 15Y AVG
+16.36%
CURRENT VS 20Y AVG
+41.49%
TMO Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | — | 0.76 | 0.71 | 0.76 | 0.76 |
| Amgen Inc. (AMGN) | $183.75B | 6.31 | 8.27 | 9.39 | 7.67 |
| Abbott Laboratories (ABT) | $154.66B | 0.29 | 0.30 | 0.38 | 0.44 |
| Gilead Sciences, Inc. (GILD) | $151.21B | 1.09 | 1.23 | 1.19 | 1.29 |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 0.02 | 0.01 | 0.01 | 0.01 |
| Pfizer Inc. (PFE) | $146.36B | 0.78 | 0.77 | 0.68 | 0.63 |
| Danaher Corporation (DHR) | $130.25B | 0.35 | 0.35 | 0.37 | 0.43 |
| CVS Health Corporation (CVS) | $125.16B | 1.24 | 1.17 | 1.09 | 1.10 |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 2.55 | 2.84 | 2.10 | 1.84 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 0.21 | 0.16 | 0.11 | 0.11 |
Financial Health
Debt/Equity
0.76
Current Ratio
1.89
Thermo Fisher Scientific Inc. Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Debt to Equity Ratio FAQ
- What is the debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The debt to equity ratio for TMO stock is 0.76.
- Is Thermo Fisher Scientific Inc.'s debt to equity ratio high or low?
- Thermo Fisher Scientific Inc.'s debt to equity ratio of 0.76 is in line with its 5-year average of 0.76, around the middle of its 5-year range (0.65–0.89).
- What is the TTM average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average debt to equity ratio for TMO stock is 0.71.
- What is the 3Y average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average debt to equity ratio for TMO stock is 0.76.
- What is the 5Y average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average debt to equity ratio for TMO stock is 0.76.
- What is the 10Y average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average debt to equity ratio for TMO stock is 0.73.
- What is the 15Y average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average debt to equity ratio for TMO stock is 0.65.
- What is the 20Y average debt to equity ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average debt to equity ratio for TMO stock is 0.54.
Thermo Fisher Scientific Inc. Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-12-31 | 0.76 |
| 2024-12-31 | 0.66 |
| 2023-12-31 | 0.78 |
| 2022-12-31 | 0.82 |
| 2021-12-31 | 0.89 |
| 2020-12-31 | 0.65 |
| 2019-12-31 | 0.62 |
| 2018-12-31 | 0.69 |
| 2017-12-31 | 0.83 |
| 2016-12-31 | 0.77 |
| 2015-12-31 | 0.58 |
| 2014-12-31 | 0.71 |
| 2013-12-31 | 0.62 |
| 2012-12-31 | 0.46 |
| 2011-12-31 | 0.47 |
| 2010-12-31 | 0.14 |
| 2009-12-31 | 0.14 |
| 2008-12-31 | 0.14 |
| 2007-12-31 | 0.15 |
| 2006-12-31 | 0.19 |
| 2005-12-31 | 0.21 |
| 2004-12-31 | 0.09 |
| 2003-12-31 | 0.12 |
| 2002-12-31 | 0.46 |
| 2001-12-31 | 0.41 |
| 2000-12-31 | 0.63 |
| 1999-12-31 | 0.83 |
| 1998-12-31 | 0.96 |
| 1997-12-31 | 0.96 |
| 1996-12-31 | 0.97 |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper